Laryngeal Cancer

Our specialists are experts in diagnosing and treating laryngeal cancer. We build a care plan that is tailored for your needs and delivered with compassion. Our head and neck surgeons specialize in minimally invasive surgery to remove laryngeal cancer and are leaders in reconstructive surgical techniques. Throughout your treatment and recovery, we offer support services such as therapy to help maintain or restore your speech and ability to swallow.

Clinical Trials and Research Studies

Phase 1

An Open Label Phase 1 Dose-Escalation Study to Evaluate the Safety and Preliminary Antitumor Activity of TAK-676 with Pembrolizumab Following Radiation Therapy in the Treatment of Non-Small-Cell Lung Cancer Triple-Negative Breast Cancer or Squamous Cell Carcinoma of the Head and Neck that has Progressed on Checkpoint Inhibitors

Learn More

Phase 4

A phase 4 single-arm open-label clinical study of pembrolizumab (MK-3475) to evaluate the efficacy and safety of MK-3475 plus carboplatin and paclitaxel as first-line treatment of recurrent/ metastatic head and neck squamous cell carcinoma.

Learn More

Phase 1

A Phase 1 Study of RTX-321 for the Treatment of Patients with Advanced Malignancies Associated with Human Papillomavirus-16 Infection

Learn More

Phase 5

Phase 1 and phase 2a first-in-human study of DRP-104 a glutamine antagonist in adult patients with advanced solid tumors

Learn More